Harald Mudra

Showing 1-11 of 11 articles

WATCHMAN versus ACP or Amulet devices for left atrial appendage occlusion: a sub-analysis of the multicentre LAARGE registry

Ledwoch J, Franke J, Akin I, Geist V, Weiß C, Zeymer U, Pleger S, Hochadel M, Mudra H, Senges J, Lewalter T, Brachmann J, Sievert H

December 4, 2020 | 10.4244/EIJ-D-19-01027

Interventions for stroke

Stroke rates after carotid artery stenting depend on study-specific definitions

Staubach S, Soekeland K, Ledwoch J, Segerer M, Strohm H, Mudra H

July 20, 2016 | 10.4244/EIJV12I4A88

Coronary interventions

Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study

Naber C, Pyxaras S, Nef H, IJsselmuiden A, Briguori C, Schlundt C, Wykrzykowska J, Eberli F, Möllmann H, Galatius S, Rieber J, Commeau P, van Geuns R, Bouchez D, Mudra H

June 20, 2016 | 10.4244/EIJY15M06_02

Transcatheter aortic valve implantation (TAVI) by centres with and without an on-site cardiac surgery programme: preliminary experience from the German TAVI registry

Eggebrecht H, Mehta R, Haude M, Sack S, Mudra H, Hein R, Brachmann J, Gerckens U, Kuck K, Zahn R, Sechtem U, Richardt G, Schneider S, Senges J

September 28, 2014 | 10.4244/EIJV10I5A105

Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery

Hein R, Abdel-Wahab M, Sievert H, Kuck K, Voehringer M, Hambrecht R, Sack S, Hauptmann K-E, Senges J, Zahn R, Mudra H

August 23, 2013 | 10.4244/EIJV9I4A73

Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: results from the German ALKK registry

Rittger H, Hochadel M, Behrens S, Hauptmann K-E, Zahn R, Mudra H, Brachmann J, Senges J, Zeymer U

February 21, 2012 | 10.4244/EIJV7I10A191

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update

Cuisset T, Valgimigli M, Mudra H, Mueller O, Wijns W, Huber K

May 25, 2010

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions

Cuisset T, Mudra H, Mueller O, Vogt P, Angelillo-Scherrer A, Huber K

August 20, 2008

Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™

Duckers H, Soullié T, den Heijer P, Rensing B, de Winter R, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys P

November 20, 2007

Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent

Duckers H, Silber S, de Winter R, den Heijer P, Rensing B, Rau M, Mudra H, Benit E, Verheye S, Wijns W, Serruys P

May 22, 2007

The European cobalt STent with Antiproliferative for Restenosis trial (EuroSTAR): 12 month results

Dawkins K, Verheye S, Schuhlen H, Dens J, Mudra H, Rutsch W, Stella P, Di Mario C, Thomas M, Serruys P, Colombo A

May 22, 2007

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....

Coronary flow capacity: where to next?

Nils P. Johnson

Joint EAPCI/ACVC expert consensus document on pVADs

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease